echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Paper Interpretation | Nature: How does the human body "remember" the new coronavirus

    Paper Interpretation | Nature: How does the human body "remember" the new coronavirus

    • Last Update: 2021-03-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    ▾ Click to listen to the content of this issue ▾ A study published online by "Nature", Evolution of Antibody Immunity to SARS-CoV-2, shows that the immunity after infection with the new coronavirus (SARS-CoV-2) may be maintained for at least 6 months.

    This study analyzed 87 people who had been infected with SARS-CoV-2 and found that their specific memory B cell levels did not change throughout the study period-memory B cells are immune cells that remain in the body after infection, and SARS- CoV-2 can rapidly multiply and produce antibodies when it is reinfected.

    The results of the study indicate that when individuals who have been infected with SARS-CoV-2 are exposed to the virus again, they may respond quickly and effectively.

    The human immune system produces antibodies during infection, and these antibodies can specifically neutralize the infectious agent.

    Human antibodies against SARS-CoV-2 have been shown to prevent infection in animal models.

    The level of these antibodies may decrease over time, but as the name suggests, memory B cells can "remember" the infectious agent and induce the immune system to produce the same antibodies during reinfection.

    Michel Nussenzweig of Rockefeller University in New York and colleagues evaluated the conditions of 87 COVID-19 confirmed patients 1.
    3 months and 6.
    2 months after being infected with SARS-CoV-2.

    They found that although the activity of neutralizing antibodies decreased over time, the number of memory B cells did not change.

    In addition, the authors proved that the antibodies produced by these cells are stronger than the original antibodies and are more resistant to mutations in the spike protein that helps the virus enter the cell.

    These observations indicate that memory B cells have the ability to evolve in the presence of a small amount of persistent viral antigens (small viral proteins that can be recognized by the immune system).

    The authors concluded that the continued existence and evolution of memory B cells indicate that when SARS-CoV-2 reinfection occurs, the human body may quickly produce powerful virus-neutralizing antibodies.

    ©Nature Nature | doi: 10.
    1038/s41586-021-03207-w
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.